Stock listing

Gilead Sciences, Inc.

Selected listing: 0QYQ · LSIN · USD · GB

Gilead Sciences, Inc. (LSIN:0QYQ), Health Technology. Latest release Sep 17, 2026: Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil…

0QYQ:LSINUSDGBUpdated October 2, 2026

Ticker: LSIN:0QYQ
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LSIN
Currency: USD

About Gilead Sciences, Inc.

The company focuses on discovering, developing, and commercializing innovative medicines in areas such as HIV, liver diseases, oncology, and inflammatory diseases. Gilead is committed to advancing healthcare through its research and development efforts.

Latest news from Gilead Sciences, Inc.

Latin America’s PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

September 17, 2026

Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention

September 16, 2026

Gilead and PAHO Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean

September 15, 2026

Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines

September 8, 2026

Gilead Sciences : Breaks Ground on New Biologics Facility as Part of $32 Billion U.S. R&D and Manufacturing Investment

August 28, 2026

All Gilead Sciences, Inc. news →

Events

Replays

Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call
Tue, Aug 04, 2026 · 04:30 PM ET
Watch
Gilead Sciences, Inc. (GILD) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Gilead Sciences, Inc. (GILD) Q4 2025 Earnings Call
Tue, Feb 10, 2026 · 04:30 PM ET
Watch

Research Gilead Sciences, Inc.

Gilead Sciences, Inc. company profile

View the public company page for Gilead Sciences, Inc. on 6ix.

Gilead Sciences, Inc. news

Read company news and market updates connected to Gilead Sciences, Inc..

Gilead Sciences, Inc. investor events

Find investor webinars, events, and replay context for Gilead Sciences, Inc..